Overview

A Trial for Acute Severe Ulcerative Colitis

Status:
Not yet recruiting
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
The goal of this trial is to create personalized treatments for each patient admitted to the hospital with acute severe ulcerative colitis (ASUC). The study will test the feasibility and acceptability of these treatment strategies among patients and physicians so that the study team can later do a larger trial to test whether the medication treatment pathways help patients avoid colectomy while ensuring patient's are safe.
Phase:
Phase 4
Details
Lead Sponsor:
Berinstein, Jeffrey
Treatments:
Cyclosporine
Cyclosporins
Methylprednisolone
Methylprednisolone Hemisuccinate
Prednisone
Upadacitinib